How many stocks does DODGE & COX own?

As of Q2 2025, DODGE & COX holds 219 positions in their 13F portfolio.

What is DODGE & COX's largest holding?

SCHW at 4.3% of portfolio, worth $7.7B.

What is DODGE & COX's total portfolio value?

$178B as of Q2 2025, tracked across 219 holdings.

Is DODGE & COX a hedge fund?

DODGE & COX is an institutional investment manager required to file SEC 13F reports. This includes hedge funds, mutual funds, pension funds, and other institutions managing over $100M.

How often does DODGE & COX report?

13F filings are due quarterly, approximately 45 days after each quarter end.

How has DODGE & COX's portfolio changed in Q2 2025?

View DODGE & COX's latest portfolio changes, new positions, and exits for Q2 2025 on HoldingsIntel.

What is DODGE & COX's investment strategy?

DODGE & COX is classified as a Steady Compounder fund based on HoldingsIntel's Fund DNA analysis of 6 behavioral dimensions.

DODGE & COX

Institutional investor · Portfolio as of Q2 2025

SEC EDGAR SourceSEC Filings

$178B

AUM

219

Positions

Q2 2025

Filing

Rating · 3.5

Quarterly Portfolio Change

Activity profile

$ moved · Q2'25

New9%Increased30%Decreased61%Exited0%

Composition

Equity vs derivatives

Equity100%Puts0%Calls0%

Holding period

Avg 4.7 years

<1Q4%1-4Q7%1-2Y9%2Y+79%

Q2 2025 Summary

Active quarter - 9 new positions, 4 exits, 60 increased. Top move: CMCSA (INCREASED, conviction 64). Portfolio: $178.0B across 219 positions.

Portfolio Allocation

Top holdings by portfolio weight

SCHW4.32%

JCI3.97%

RTX3.43%

FISV2.88%

CVS2.84%

CHTR2.56%

MET2.40%

BKNG2.38%

WFC2.28%

MSFT2.28%

Other2.23%

Sector Breakdown

Portfolio allocation by GICS sector

Healthcare23.24%

Financial Services18.09%

Industrials12.75%

Communication Services11.57%

Technology8.85%

Consumer Cyclical6.91%

Basic Materials5.47%

Energy4.34%

Unknown2.89%

Real Estate2.50%

Other3.39%

Fund DNA

Behavioral investing profile

Steady Compounder92%- primarily Healthcare, Financial Services, Industrials

Compare DNA across all funds

Fund Rating

7-dimension quality assessment

Strong(3.5 / 5.0)

Track Record78

Conviction37

Concentration0

Upgrade to see all dimensions

Position Outcomes

Best and worst performing positions by estimated return

Top Winners

LLY27Q held

ELI LILLY & CO

Avg $108.29 · $29.8M est. P&L

Est. P&L

+612.29%

CDNS27Q held

CADENCE DESIGN SYSTEM INC

Avg $43.34 · $64.5M est. P&L

Est. P&L

+604.20%

AMP27Q held

AMERIPRISE FINL INC

Avg $90.28 · $790,598 est. P&L

Est. P&L

+479.32%

Top Losers

Upgrade to Pro to see the worst-performing positions.

View plans

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Holdings219 positions

Export CSV(Pro)

Activity:

Stock	Shares	Value	Weight	Price Trend	Avg Buy	Est. P&L	Held	Conviction
SCHW SCHWAB CHARLES CORP	84.4M	$7.7B	4.3%	—	$43.26	+106.12%	27 qtrssince 2018-Q4	Decreased 0
JCI JOHNSON CONTROLS INTERNATION	66.9M	$7.1B	4.0%	—	$36.75	+185.87%	27 qtrssince 2018-Q4	Decreased 0
RTX RTX CORPORATION	41.8M	$6.1B	3.4%	—	$63.25	+126.81%	21 qtrssince 2020-Q2	Decreased 0
FISV FISERV INC	29.7M	$5.1B	2.9%	—	$110.20	+56.38%	19 qtrssince 2020-Q4	Decreased 0
CVS CVS HEALTH CORP	73.3M	$5.1B	2.8%	—	$58.36	+14.21%	27 qtrssince 2018-Q4	Decreased 0
CHTR CHARTER COMMUNICATIONS INC	11.1M	$4.5B	2.6%	—	$351.10	+14.21%	27 qtrssince 2018-Q4	Decreased 0
MET METLIFE INC	53.2M	$4.3B	2.4%	—	$32.87	+139.18%	27 qtrssince 2018-Q4	Decreased 0
BKNG BOOKING HOLDINGS INC	730,473	$4.2B	2.4%	—	$67.25	+242.32%	27 qtrssince 2018-Q4	Decreased 0
WFC WELLS FARGO & CO	50.7M	$4.1B	2.3%	—	$31.45	+148.77%	27 qtrssince 2018-Q4	Decreased 0
MSFT MICROSOFT CORP	8.1M	$4.1B	2.3%	—	$125.63	+293.39%	27 qtrssince 2018-Q4	Decreased 0
CMCSA COMCAST CORP NEW	111.3M	$4B	2.2%	—	$29.54	+8.61%	27 qtrssince 2018-Q4	Increased 64
AMZN AMAZON COM INC	16.6M	$3.6B	2.0%	—	$103.37	+116.01%	27 qtrssince 2018-Q4	Increased 55
SNY ADR SANOFI SA	71.7M	$3.5B	1.9%	—	$37.94	+26.11%	27 qtrssince 2018-Q4	Decreased 0
BK BANK NEW YORK MELLON CORP	37.6M	$3.4B	1.9%	—	$36.17	+148.43%	27 qtrssince 2018-Q4	Decreased 0
GILD GILEAD SCIENCES INC	30.8M	$3.4B	1.9%	—	$53.29	+104.90%	27 qtrssince 2018-Q4	Decreased 0
OXY OCCIDENTAL PETE CORP	80.3M	$3.4B	1.9%	—	$37.31	+12.91%	27 qtrssince 2018-Q4	Decreased 0
FDX FEDEX CORP	14.5M	$3.3B	1.8%	—	$172.29	+31.34%	27 qtrssince 2018-Q4	Increased 53
META META PLATFORMS INC	4.2M	$3.1B	1.7%	—	$324.16	+125.98%	21 qtrssince 2020-Q2	Increased 59
GSK ADR GSK PLC	78.8M	$3B	1.7%	—	$28.12	+34.54%	12 qtrssince 2022-Q3	Increased 50
CI THE CIGNA GROUP	9M	$3B	1.7%	—	$188.10	+71.64%	27 qtrssince 2018-Q4	Increased 50
Showing 20 of 219 results.199 more with Pro.PROUpgrade to see all →